Circulating tumour DNA (ctDNA) as a diagnostic tool in colorectal cancer: role in screening and early detection of metastatic or recurrent disease

点击翻译按钮获取中文摘要

These studies will be exploring the value of using a blood test to detect cancer DNA as a screening test for colorectal cancer. This test promises to be superior to faecal blood testing, which is currently performed as part of the National Bowel Cancer Screening Program. It may also have advantages over colonoscopy as a screening tool. Given the likely acceptability of having a blood based screening test, it is expected that participation rates in bowel cancer screening, which has been shown to save lives, will be greatly increased.